Major Companies to Ramp Up Vaccine Adjuvant Production in 2021
The key players are forming various strategies such as acquisitions, mergers, partnerships, collaborations, and launching new products to strengthen their position in the global vaccine adjuvants market. Companies are also expanding their R&D, distribution, and management facilities to expand their business and to hold a competitive edge in the vaccine adjuvants market. For instance, in May 2020; GlaxoSmithKline announced that it will expand production of vaccine adjuvants to 1 billion doses in 2021. Additionally, the company announced that the vaccine adjuvants would be supplied to partner’s of COVID-19 vaccine candidates. These factors are projected to boost vaccine adjuvants market growth over the forecast period from 2021 to 2031.

Rising Demand from Emerging Economies to Offer Lucrative Revenue Generation Avenues
For the companies operating in the global vaccine adjuvants market, there is an immense opportunity from emerging economies across the globe. In the emerging economies, vaccine manufacturers and respective governments are investing in enhancing production capacity, which is anticipated to reduce the amount of protein required per dose over the forecast period. In addition to the demand arising from the ageing population and rising birth rates, the economic growth across the emerging markets is another major factor that is driving demand for the vaccine adjuvants.

Discover how to stay ahead
Our 310+ page report provides 450+ tables and charts/graphs. Read on to discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales at overall world market and regional level. See financial results, trends, opportunities, and revenue predictions. Much opportunity remains in this growing Vaccine Adjuvants Market. See how to exploit the opportunities.

This report includes data analysis and invaluable insight into how COVID-19 will affect your industry. Access this report today.

Forecasts to 2031 and other analyses reveal the commercial prospects

  • In addition to revenue forecasting to 2031, our new study provides you with recent results, growth rates, and market shares.
  • You find original analyses, with business outlooks and developments.
  • Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints, and challenges), PEST Analysis, SWOT Analysis, product profiles and commercial developments.

Discover sales predictions for the world market and sub-markets

Type

  • Pathogen
  • Adjuvant Emulsion
  • Particulate
  • Combination
  • Others
  • Route of Administration
  • Intramuscular
  • Subcutaneous
  • Intradermal
  • Others

Disease Type

  • Infectious Diseases
  • Cancer
  • Others

End-User

  • Pediatric
  • Adults
  • Others

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for 5 regional and 14 leading national markets:

By Region

North America

  • U.S.
  • Canada

Europe

  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe

Asia Pacific

  • China
  • Japan
  • India
  • Rest of Asia Pacific

Latin America

  • Brazil
  • Mexico
  • Rest of Latin America

Middle East & Africa

  • GCC
  • South Africa
  • Rest of Middle East & Africa